| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.003 |